好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Therapeutic Monoclonal Antibodies for Prion Exposure Prophylaxis
Infections/AIDS/Prion Disease
(-)
134
Authors/Disclosures
Martin J. Sadowski, MD, PhD (New York University School of Medicine) The institution of Dr. Sadowski has received research support from National Institute on Aging. The institution of Dr. Sadowski has received research support from Biogen. The institution of Dr. Sadowski has received research support from Novartis. The institution of Dr. Sadowski has received research support from Janssen Research and Development. The institution of Dr. Sadowski has received research support from Eisai. The institution of Dr. Sadowski has received research support from TauRx Therapeutics Ltd. The institution of Dr. Sadowski has received research support from Suven Life Sciences Ltd.. The institution of Dr. Sadowski has received research support from Merck Sharp & Dohme Corp.. The institution of Dr. Sadowski has received research support from Alzheimer's Disease Cooperative Study. The institution of Dr. Sadowski has received research support from Neurotrack Technologies Inc.. Dr. Sadowski has received intellectual property interests from a discovery or technology relating to health care. Dr. Sadowski has received personal compensation in the range of $100,000-$499,999 for serving as a VA Physician with Veterans' Affairs.
Joanna Pankiewicz, MD, PhD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Thomas M. Wisniewski, MD (New York University School of Medicine) Dr. Wisniewski has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Aging Neuroscience. The institution of Dr. Wisniewski has received research support from the National Institute of Aging. Dr. Wisniewski has received intellectual property interests from a discovery or technology relating to health care.